当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • 索引コペルニクス
  • Google スカラー
  • シェルパ・ロミオ
  • Genamics JournalSeek
  • セーフティライト付き
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • ICMJE
このページをシェアする

抽象的な

Knowledge and Practice Regarding Hereditary Cancer Syndromes among Family Physicians

De Nagy J1,2, Rycroft R3, Ku L4, Axell L4 and Lowery JT5,6*

Objective: To assess current knowledge and practices around hereditary cancer among family physicians in Colorado.

Methods: We surveyed a random sample of 300 family physicians to assess: knowledge and comfort in management of at-risk patients, use of family history to inform clinical decisions, guidelines used for screening and genetic referrals, and frequency of referrals with and without involvement of genetic counselors. We generated descriptive statistics and compared physicians that reported greater knowledge around management of high risk patients and routine use of family history to inform practices, to those who did not, with respect to demographic and practice characteristics.

Results: A minority of physicians reported high knowledge of hereditary cancer syndromes, recommendations for screening high risk patients, and risk assessment; only 10% reported high level of comfort in referring their patients for genetic risk assessment. Physicians who collected complete family histories were more likely to report high knowledge about hereditary cancer, and to use family history to guide recommendations. Few physicians reported using recommendations from organizations focused on high risk patients

Conclusions: Physician-focused education initiatives should focus on raising awareness of hereditary cancer syndromes in primary care settings, use of risk-appropriate guidelines, and the importance of collecting comprehensive family histories to identify patients at risk.